For development of Therapeutics, Devices & Diagnostics

New Drug Approval

Faster Approvals Leading to Enhanced Access to Markets !

Any drug including bulk drug substance which have not been used in the country to any significant extent and has not been recognized as effective and safe by the Indian licensing authority (CDSCO) are considered as New Drugs. All activities with reference to a New Drug, including Import, Manufacturing, Testing, Conduct of Clinical Trials, Marketing etc., have to be approved by the Central Drug Regulator – CDSCO. One category of “New Drug” encompasses all biological products including vaccines, biosimilars, rDNA Derived Products etc.,

In brief, there is a set procedure of application submission, review and approvals from various stakeholders that are required to initiate any and all activities indicated. The approvals are usually in the form of No Objection Certificates/Letters, Approval Letters, Licences etc.,

Vyomus Consulting provides both New Drug Registration Services and Authorised Agent Services to all categories of New Drugs in India. An end-to-end service offering which will help you import, manufacture, test, conduct clinical trials and sell your product in India (Market Authorisation), efficiently so as to achieve faster product approvals leading to enhanced access to Markets and Opportunities.

This service offering includes vendor identification & management, various stakeholder regulatory submissions, approvals management, independent audit, regulatory reporting, regulatory dossier review and submission to the regulator.

Our services include the following :

Discuss Your Needs

Thank you for your interest in Vyomus Consulting. To conact us, please complete the form below or send us email at

First Name *
Last Name *
E-mail address (so we may contact you) *
Telephone No *
Please leave this field empty.
Message *

Back to Top